Structure-based prediction and biosynthesis of the major mammalian metabolite of the cardioactive prototype LASSBio-294.

A new bioactive compound of the N-acylhydrazone class, LASSBio-294, was shown to produce a cardioinotropic effect and vasodilation. In this study, we report the structure-based drug metabolism prediction, biosynthesis and identification of the major mammalian metabolite of LASSBio-294.

[1]  Franco Lombardo,et al.  In silico ADME prediction: data, models, facts and myths. , 2003, Mini reviews in medicinal chemistry.

[2]  G. Stokes.  Systolic Hypertension in the Elderly: Pushing the Frontiers of Therapy—A Suggested New Approach , 2004, Journal of clinical hypertension.

[3]  K. Gates.  Abstracts, American Chemical Society Division of Chemical Toxicology, 236th ACS National Meeting, Philadelphia, PA, August 17−21, 2008 , 2008 .

[4]  E. Barreiro,et al.  Design and synthesis of novel potent antinociceptive agents: methyl-imidazolyl N-acylhydrazone derivatives. , 2000, Bioorganic & medicinal chemistry.

[5]  E. Barreiro,et al.  Cyclic GMP‐dependent vasodilatory properties of LASSBio 294 in rat aorta , 2002, British journal of pharmacology.

[6]  G. Buchanan,et al.  Biotransformation of cadinane sesquiterpenes by Beauveria bassiana ATCC 7159. , 2000, Phytochemistry.

[7]  J. Rosazza,et al.  Microbial models of mammalian metabolism. Aromatic hydroxylation. , 1974, Archives of biochemistry and biophysics.

[8]  E. Barreiro,et al.  The new compound, LASSBio 294, increases the contractility of intact and saponin‐skinned cardiac muscle from Wistar rats , 2001, British journal of pharmacology.

[9]  Hao Sun,et al.  Structure‐based Drug Metabolism Predictions for Drug Design , 2010, Chemical biology & drug design.

[10]  S. Jacob,et al.  Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents? , 1998, American journal of hypertension.

[11]  T. Andersson.  Pharmacokinetics, Metabolism and Interactions of Acid Pump Inhibitors , 1996, Clinical pharmacokinetics.

[12]  M. Vidyavathi,et al.  Cunninghamella--a microbial model for drug metabolism studies--a review. , 2009, Biotechnology advances.

[13]  J. Rosazza,et al.  Microbial models of mammalian metabolism. , 1975, Journal of natural products.

[14]  J. Prieto,et al.  Small intestinal sulphoxidation of albendazole. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.

[15]  L. M. Lima,et al.  Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole. , 2000, European journal of medicinal chemistry.